OR WAIT null SECS
June 19, 2019
Biotech company Genmab signed an agreement with Johnson & Johson’s Janssen Biotech to develop a monoclonal antibody product using Genmab’s HexaBody technology.
The companies have signed a strategic multi-year manufacturing agreement for the future commercial production a late-phase investigational cell therapy.
Catalent will manufacture products for Bristol-Myers Squibb while adding sterile biologics fill/finish and oral solids manufacturing and packaging capacity.
June 18, 2019
Centre for Process Innovation (CPI) is set to host an event in Darlington, UK, on June 26, 2019 to showcase the results of a £11.2-million (US$14.03-million) collaborative project to optimize biotherapeutic development.
June 14, 2019
GSK has revealed that it has entered into a five-year collaboration with the University of California to advance genomic research and improve drug discovery.
June 13, 2019
The acquisition will boost Merck’s pipeline for cancer, fibrosis, and autoimmune disease therapeutics.
June 07, 2019
The acquisition will boost Biogen’s gene-therapy pipeline with the addition of two mid- to late-stage clinical assets and preclinical programs.
June 06, 2019
Cambrex has announced the completion of its new facility at its Karlskoga site in Sweden that combines new laboratories for process and analytical development.
A new United Kingdom life-science asset, HIRANI, was launched at a reception at BIO in Philadelphia.
Biotage has announced a strategic collaboration with Shandong Yingsheng Biotechnology for the development of clinical MS applications in China.